- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of COVID-19 Recombinant Protein Vaccine will have significant change from previous year. By the most conservative estimates of global COVID-19 Recombinant Protein Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the COVID-19 Recombinant Protein Vaccine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Recombinant Protein Vaccine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the COVID-19 Recombinant Protein Vaccine, covering the supply chain analysis, impact assessment to the COVID-19 Recombinant Protein Vaccine market size growth rate in several scenarios, and the measures to be undertaken by COVID-19 Recombinant Protein Vaccine companies in response to the COVID-19 epidemic.
Segmentation by product type:
Being Developed
Preclinical
Clinical I
Clinical II
Segmentation by Application:
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:
GSK
Johnson & Johnson
Novavax
Pukang Biologic Technology
Sanofi
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global COVID-19 Recombinant Protein Vaccine market size by key regions/countries, type and application.
To understand the structure of COVID-19 Recombinant Protein Vaccine market by identifying its various subsegments.
Focuses on the key global COVID-19 Recombinant Protein Vaccine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the COVID-19 Recombinant Protein Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of COVID-19 Recombinant Protein Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the COVID-19 Recombinant Protein Vaccine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global COVID-19 Recombinant Protein Vaccine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COVID-19 Recombinant Protein Vaccine Market Size 2021-2025
2.1.2 COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region
2.2 COVID-19 Recombinant Protein Vaccine Segment by Type
2.2.1 Being Developed
2.2.2 Preclinical
2.2.3 Clinical I
2.2.4 Clinical II
2.3 COVID-19 Recombinant Protein Vaccine Market Size by Type
2.3.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
2.3.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Type (2021-2025)
2.4 COVID-19 Recombinant Protein Vaccine Segment by Application
2.4.1 Pharmaceutical And Biotechnology Companies
2.4.2 Hospital
2.4.3 Academic And Research Organizations
2.4.4 Other
2.5 COVID-19 Recombinant Protein Vaccine Market Size by Application
2.5.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
2.5.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Application (2021-2025)
3 COVID-19 Recombinant Protein Vaccine Key Players
3.1 Date of Key Players Enter into COVID-19 Recombinant Protein Vaccine
3.2 Key Players COVID-19 Recombinant Protein Vaccine Product Offered
3.3 Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 COVID-19 Recombinant Protein Vaccine by Regions
4.1 COVID-19 Recombinant Protein Vaccine Market Size by Regions (2015-2020)
4.2 Americas COVID-19 Recombinant Protein Vaccine Market Size Growth (2015-2020)
4.3 APAC COVID-19 Recombinant Protein Vaccine Market Size Growth (2015-2020)
4.4 Europe COVID-19 Recombinant Protein Vaccine Market Size Growth (2015-2020)
5 Americas
5.1 Americas COVID-19 Recombinant Protein Vaccine Market Size by Countries (2021-2025)
5.2 Americas COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025)
5.3 Americas COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC COVID-19 Recombinant Protein Vaccine Market Size by Regions
6.2 APAC COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025)
6.3 APAC COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe COVID-19 Recombinant Protein Vaccine by Countries (2021-2025)
7.2 Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025)
7.3 Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in COVID-19 Recombinant Protein Vaccine
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 GSK
10.1.1 GSK Company Information
10.1.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.1.3 GSK COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.1.4 Main Business Overview
10.1.5 GSK Latest Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.2.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.2.4 Main Business Overview
10.2.5 Johnson & Johnson Latest Developments
10.3 Novavax
10.3.1 Novavax Company Information
10.3.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.3.3 Novavax COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.3.4 Main Business Overview
10.3.5 Novavax Latest Developments
10.4 Pukang Biologic Technology
10.4.1 Pukang Biologic Technology Company Information
10.4.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.4.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.4.4 Main Business Overview
10.4.5 Pukang Biologic Technology Latest Developments
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.5.3 Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.5.4 Main Business Overview
10.5.5 Sanofi Latest Developments
10.6 Clover Biopharmaceuticals
10.6.1 Clover Biopharmaceuticals Company Information
10.6.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.6.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.6.4 Main Business Overview
10.6.5 Clover Biopharmaceuticals Latest Developments
10.7 Suzhou Yuzhibo Biotechnology
10.7.1 Suzhou Yuzhibo Biotechnology Company Information
10.7.2 COVID-19 Recombinant Protein Vaccine Product Offered
10.7.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
10.7.4 Main Business Overview
10.7.5 Suzhou Yuzhibo Biotechnology Latest Developments
...
11 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global COVID-19 Recombinant Protein Vaccine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by COVID-19 Recombinant Protein Vaccine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region (2021-2025) ($ Millions)
Table 6. Major Players of Being Developed
Table 7. Major Players of Preclinical
Table 8. Major Players of Clinical I
Table 9. Major Players of Clinical II
Table 10. Global Market Size by Type (2021-2025) ($ Millions)
Table 11. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
Table 12. Global COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025) ($ Millions)
Table 13. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
Table 14. Date of Global Key Players Enter into COVID-19 Recombinant Protein Vaccine Market
Table 15. Global Key Players COVID-19 Recombinant Protein Vaccine Product Offered
Table 16. Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment ($ Millions)
Table 17. Funding/Investment by Regions
Table 18. Funding/Investment by End Industry
Table 19. Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization ($ Millions)
Table 20. Key Players Mergers & Acquisitions, Expansion Plans
Table 21. COVID-19 Recombinant Protein Vaccine New Product/Technology Launches
Table 22. COVID-19 Recombinant Protein Vaccine Industry Partnerships, Agreements, and Collaborations
Table 23. COVID-19 Recombinant Protein Vaccine Industry Mergers and Acquisitions
Table 24. Global COVID-19 Recombinant Protein Vaccine Market Size by Regions 2021-2025 ($ Millions)
Table 25. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2021-2025
Table 26. Americas COVID-19 Recombinant Protein Vaccine Market Size by Countries (2021-2025) ($ Millions)
Table 27. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Countries (2021-2025)
Table 28. Americas COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025) ($ Millions)
Table 29. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
Table 30. Americas COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025) ($ Millions)
Table 31. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
Table 32. APAC COVID-19 Recombinant Protein Vaccine Market Size by Regions (2021-2025) ($ Millions)
Table 33. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions (2021-2025)
Table 34. APAC COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025) ($ Millions)
Table 35. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
Table 36. APAC COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025) ($ Millions)
Table 37. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
Table 38. Europe COVID-19 Recombinant Protein Vaccine Market Size by Countries (2021-2025) ($ Millions)
Table 39. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Countries (2021-2025)
Table 40. Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2021-2025) ($ Millions)
Table 41. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
Table 42. Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2021-2025) ($ Millions)
Table 43. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
Table 44. Key and Potential Regions of COVID-19 Recombinant Protein Vaccine
Table 45. Key Application and Potential Industries of COVID-19 Recombinant Protein Vaccine
Table 46. Key Challenges of COVID-19 Recombinant Protein Vaccine
Table 47. Key Trends of COVID-19 Recombinant Protein Vaccine
Table 48. Company A Company Details
Table 49. Companies Invested by Company A
Table 50. Company A Key Development and Market Layout
Table 51. Company B Company Details
Table 52. Companies Invested by Company B
Table 53. Company B Key Development and Market Layout
Table 54. Company C Company Details
Table 55. Companies Invested by Company C
Table 56. Company C Key Development and Market Layout
Table 57. Company C Company Details
Table 58. Companies Invested by Company C
Table 59. Company C Key Development and Market Layout
Table 60. GSK Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. GSK COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 62. Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 64. Novavax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Novavax COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 66. Pukang Biologic Technology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 68. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 70. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
Table 72. Suzhou Yuzhibo Biotechnology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2020 VS 2025)
List of Figures
Figure 1. Picture of COVID-19 Recombinant Protein Vaccine
Figure 2. COVID-19 Recombinant Protein Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate 2021-2025 ($ Millions)
Figure 5. COVID-19 Recombinant Protein Vaccine Market Size by Region (2020 & 2025) ($ millions)
Figure 6. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2021-2025)
Figure 7. Global Being Developed Market Size Growth Rate
Figure 8. Global Preclinical Market Size Growth Rate
Figure 9. Global Clinical I Market Size Growth Rate
Figure 10. Global Clinical II Market Size Growth Rate
Figure 11. COVID-19 Recombinant Protein Vaccine Consumed in Pharmaceutical And Biotechnology Companies
Figure 12. Global COVID-19 Recombinant Protein Vaccine Market: Pharmaceutical And Biotechnology Companies (2021-2025) ($ Millions)
Figure 13. Global Pharmaceutical And Biotechnology Companies YoY Growth ($ Millions)
Figure 14. COVID-19 Recombinant Protein Vaccine Consumed in Hospital
Figure 15. Global COVID-19 Recombinant Protein Vaccine Market: Hospital (2021-2025) ($ Millions)
Figure 16. Global Hospital YoY Growth ($ Millions)
Figure 17. COVID-19 Recombinant Protein Vaccine Consumed in Academic And Research Organizations
Figure 18. Global COVID-19 Recombinant Protein Vaccine Market: Academic And Research Organizations (2021-2025) ($ Millions)
Figure 19. Global Academic And Research Organizations YoY Growth ($ Millions)
Figure 20. COVID-19 Recombinant Protein Vaccine Consumed in Other
Figure 21. Global COVID-19 Recombinant Protein Vaccine Market: Other (2021-2025) ($ Millions)
Figure 22. Global Other YoY Growth ($ Millions)
Figure 23. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2021-2025)
Figure 24. Global COVID-19 Recombinant Protein Vaccine Market Size in Pharmaceutical And Biotechnology Companies Growth Rate
Figure 25. Global COVID-19 Recombinant Protein Vaccine Market Size in Hospital Growth Rate
Figure 26. Global COVID-19 Recombinant Protein Vaccine Market Size in Academic And Research Organizations Growth Rate
Figure 27. Global COVID-19 Recombinant Protein Vaccine Market Size in Other Growth Rate
Figure 28. Funding/Investment
Figure 29. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2021-2025
Figure 30. Americas COVID-19 Recombinant Protein Vaccine Market Size 2021-2025 ($ Millions)
Figure 31. APAC COVID-19 Recombinant Protein Vaccine Market Size 2021-2025 ($ Millions)
Figure 32. Europe COVID-19 Recombinant Protein Vaccine Market Size 2021-2025 ($ Millions)
Figure 33. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Countries in 2020
Figure 34. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type in 2020
Figure 35. Americas COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2020
Figure 36. United States COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 37. Canada COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 38. Mexico COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 39. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions in 2020
Figure 40. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type in 2020
Figure 41. APAC COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2020
Figure 42. China COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 43. Japan COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 44. Korea COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 45. Southeast Asia COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 46. India COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 47. Australia COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 48. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Countries in 2020
Figure 49. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type in 2020
Figure 50. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2020
Figure 51. Germany COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 52. France COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 53. UK COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 54. Italy COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Figure 55. Russia COVID-19 Recombinant Protein Vaccine Market Size Growth 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
